Catalent Clinical Supply Content

  1. Making The Case For Case Management For Cell And Gene Therapies

    It is crucial to ensure that CGT supply chain risks are mitigated, as well as to have proactive strategies in place to address unforeseen challenges before they become an issue.

  2. Proactive Strategies To Evaluate And Mitigate Clinical Supply Risk

    Learn about strategies that can help build an understanding of risk assessment, in addition to how a study’s protocol requirements, packaging specifications, and more must be identified and addressed.